Why Palantir Technologies Shares Are Trading Higher By 18%; Here Are 20 Stocks Moving Premarket

Shares of Palantir Technologies Inc. PLTR rose sharply during today’s pre-market trading after the company reported better-than-expected fourth-quarter sales results and issued guidance.

Palantir said fourth-quarter revenue increased 20% year-over-year to $608 million, which beat the consensus estimate of $602.41 million, according to Benzinga Pro. Palantir reported quarterly adjusted earnings of 8 cents per share, which was in line with analyst estimates.

Palantir expects first-quarter revenue to be between $612 million and $616 million versus estimates of $617.21 million. First-quarter adjusted income from operations is expected to be between $196 million and $200 million.

Palantir Technologies shares jumped 18.2% to $19.77 in pre-market trading

Here are some other stocks moving in pre-market trading.

Gainers

InVivo Therapeutics Holdings Corp. NVIV gained 54.2% to $0.3424 in pre-market trading after dipping around 26% on Monday.
Chenghe Acquisition Co. CHEA shares jumped 43.2% to $10.08 in pre-market trading. Chenghe Acquisition shares jumped 28% on Monday after shareholders on Friday voted to approve the merger agreement with Taiwan Color Optics, Inc.
Exicure, Inc. XCUR gained 36.2% to $0.75 in pre-market trading after the company announced it entered into a patent license agreement with Bluejay Therapeutics to develop cavrotolimod for the potential treatment for hepatitis.
Gorilla Technology Group Inc. GRRR shares gained 17.4% to $1.28 in pre-market trading. Gorilla Technology shares jumped 96% on Monday after the company reported results through the third quarter of 2023.
NanoString Technologies, Inc. NSTG shares gained 13.7% to $0.1171 in pre-market trading. NanoString Technologies shares dipped 78% on Monday after the company initiated voluntary Chapter 11 restructuring proceedings.
Sangamo Therapeutics, Inc. SGMO shares rose 12.3% to $0.6289 in pre-market trading after reporting updated preliminary data from Phase 1/2 STAAR clinical study evaluating Isaralgagene Civaparvovec, or ST-920.
SOS Limited SOS shares rose 10.7% to $3.32 in pre-market trading after dipping more than 7% on Monday.
Vicarious Surgical Inc. RBOT gained 10.4% to $0.43 in pre-market trading. Vicarious Surgical recently named Randy Clark as President.
Airgain, Inc. AIRG shares rose 8.8% to $4.90 in pre-market trading.

Losers

Peraso Inc. PRSO declined 29.5% to $2.15 in pre-market trading after dipping around 25% on Monday.
Trio Petroleum Corp. TPET fell 28.1% to $0.1545 in pre-market trading.
Trio Petroleum issued an update on its operations in Monterey County, California.
Symbotic Inc. SYM fell 21.2% to $2.15 in pre-market trading after the company reported mixed first-quarter financial results.
FMC Corporation FMC shares declined 15.4% to $51.10 in pre-market trading after the company reported worse-than-expected fourth-quarter results.
C3is Inc. CISS shares declined 12.2% to $0.1302 in pre-market trading. C3is shares fell around 8% on Monday after the company filed for an offering of 43.75 million units.
Crown ElectroKinetics Corp. CRKN shares dipped 10.8% to $0.1059 in pre-market trading after declining over 3% on Monday.
Rambus Inc. RMBS shares fell 10.4% to $61.20 in pre-market trading after the company reported mixed quarterly financial results.
Elevai Labs, Inc. ELAB shares declined 10.2% to $0.68 in pre-market trading after dipping around 9% on Monday.
Nyxoah S.A. NYXH shares fell 10% to $9.65 in pre-market trading.
Chegg, Inc. CHGG shares declined 8.8% to $8.48 in pre-market trading after the company issued weak first-quarter guidance.